ID=H0166
URL=http://hiv-web.lanl.gov/content/hiv-db/REVIEWS/Brander2000.html
SIZE=115358
DATE=11/07/2002
TIME=17:02:09
DATASET=Biology
HTML=  
<html>
  <head>
    <title></title>
      <style type="text/css">
	<!--
	  span.red {color: red}
	  span.green {color: green}
          span.small {size:"-1"}
	  input.lavender {background: lavender;
			  color: green}
	  ul.tip {list-style-type: none} 
	  .a11 {color: black; 
                font-size: 11pt; 
                font-weight: normal; 
                text-decoration: none; 
                font-family: Arial, Helvetica, sans-serif}
          a:link {color: blue; 
                  text-decoration : none; 
                  font-weight: normal}
	  a:visited {color : blue;
                     text-decoration : none;
                     font-weight : normal}
          a:hover {color: brown; 
                   text-decoration : none; 
                   font-weight: normal}
#pup {position:absolute; visibility:hidden; z-index:200; width:130; }
//-->
      </style>	
  </head>
  <body bgcolor="white">
    <table bgcolor="white" width="100%" border=0 cellspacing=0 cellpadding=3>
      <tr valign="top">
	<td width="10%" bgcolor="#eaeaea">
               <!--
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">

<HTML>

<HEAD>
  <TITLE>
    HIV sequence database navigation frame
  </TITLE>
</HEAD>


<BODY> 
	BACKGROUND="" 
	BGCOLOR="#eaeaea" 
	TEXT="#000000" 
	LINK="#0000ff" 
	VLINK="#800080" 
	ALINK="#ff0000"
-->

<A HREF="/content/hiv-db/mainpage.html">
	
<IMG SRC="/content/hiv-db/IMAGES/VirusTransparent.gif" BORDER=0></A>

<P>
<CENTER>
</CENTER>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/headerDatabases.gif" BORDER=0></A><BR>

<A HREF="/content/hiv-db/mainpage.html" 
	onMouseOver="document.Sequence.src='/content/hiv-db/NAVIFRAME/YELLOW/_SequenceDB.gif' "
	onMouseOut="document.Sequence.src='/content/hiv-db/NAVIFRAME/YELLOW/SequenceDB.gif' " >
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/SequenceDB.gif" BORDER=0 NAME="Sequence"></A><BR>

<A HREF="http://resdb.lanl.gov/Resist_DB/default.htm" 
	onMouseOver="document.Resistance.src='/content/hiv-db/NAVIFRAME/YELLOW/_ResistanceDB.gif' "
	onMouseOut="document.Resistance.src='/content/hiv-db/NAVIFRAME/YELLOW/ResistanceDB.gif'">
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/ResistanceDB.gif" BORDER=0 NAME="Resistance"></A><BR>

<A HREF="/content/immunology/index" 
	onMouseOver="document.Immunology.src='/content/hiv-db/NAVIFRAME/YELLOW/_ImmunologyDB.gif' "
	onMouseOut="document.Immunology.src='/content/hiv-db/NAVIFRAME/YELLOW/ImmunologyDB.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/ImmunologyDB.gif" BORDER=0 NAME="Immunology"></A><BR>

<A HREF="/content/vaccine/html/index.html" 
	onMouseOver="document.VaccineTrials.src='/content/hiv-db/NAVIFRAME/YELLOW/_VaccinetrialsDB.gif' "
	onMouseOut="document.VaccineTrials.src='/content/hiv-db/NAVIFRAME/YELLOW/VaccinetrialsDB.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/VaccinetrialsDB.gif" BORDER=0 NAME="VaccineTrials"></A><BR>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/bottom.gif" BORDER=0></A><BR>

<P>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/headerPublications.gif" BORDER=0></A><BR>

<A HREF="/content/hiv-db/HTML/FAQ.html" 
	onMouseOver="document.Faq.src='/content/hiv-db/NAVIFRAME/YELLOW/_FAQ.gif' "
	onMouseOut="document.Faq.src='/content/hiv-db/NAVIFRAME/YELLOW/FAQ.gif' ">
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/FAQ.gif" BORDER=0 NAME="Faq"></A><BR>

<A HREF="/content/hiv-db/ALIGN_CURRENT/ALIGN-INDEX.html" 
	onMouseOver="document.Alignments.src='/content/hiv-db/NAVIFRAME/YELLOW/_Alignments.gif' "
	onMouseOut="document.Alignments.src='/content/hiv-db/NAVIFRAME/YELLOW/Alignments.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Alignments.gif" BORDER=0 NAME="Alignments"></A><BR>

<A HREF="/content/hiv-db/HTML/Tutorials.html" 
	onMouseOver="document.Tutorials.src='/content/hiv-db/NAVIFRAME/YELLOW/_Tutorials.gif' "
	onMouseOut="document.Tutorials.src='/content/hiv-db/NAVIFRAME/YELLOW/Tutorials.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Tutorials.gif" BORDER=0 NAME="Tutorials"></A><BR>

<A HREF="/content/hiv-db/REVIEWS/reviews.html" 
	onMouseOver="document.Reviews.src='/content/hiv-db/NAVIFRAME/YELLOW/_Reviews.gif' "
	onMouseOut="document.Reviews.src='/content/hiv-db/NAVIFRAME/YELLOW/Reviews.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Reviews.gif" BORDER=0 NAME="Reviews"></A><BR>

<A HREF="/content/hiv-db/HTML/compendium.html" 
	onMouseOver="document.Compendia.src='/content/hiv-db/NAVIFRAME/YELLOW/_Compendia.gif' "
	onMouseOut="document.Compendia.src='/content/hiv-db/NAVIFRAME/YELLOW/Compendia.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Compendia.gif" BORDER=0 NAME="Compendia"></A><BR>

<A HREF="/content/hiv-db/HTML/links.html" 
	onMouseOver="document.Links.src='/content/hiv-db/NAVIFRAME/YELLOW/_Links.gif' "
	onMouseOut="document.Links.src='/content/hiv-db/NAVIFRAME/YELLOW/Links.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Links.gif" BORDER=0 NAME="Links"></A><BR>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/bottom.gif" BORDER=0></A><BR>

<P>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/headerSequenceDB.gif" BORDER=0></A><BR>

<!--
<A HREF="/content/hiv-db/MAP/hivmap.html" 
-->
<A HREF="/content/hiv-db/combined_search/search" 
	onMouseOver="document.Hivmap.src='/content/hiv-db/NAVIFRAME/YELLOW/_Search&Align.gif'"
	onMouseOut="document.Hivmap.src='/content/hiv-db/NAVIFRAME/YELLOW/Search&Align.gif'">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Search&Align.gif" BORDER=0 NAME="Hivmap"></A><BR>

<!--
<A HREF="/cgi-bin/hivDB3/public/wdb/ssampublic" 
-->
<A HREF="/content/hiv-db/combined_search/search" 
	onMouseOver="document.Searchdb.src='/content/hiv-db/NAVIFRAME/YELLOW/_SearchDB.gif' "
	onMouseOut="document.Searchdb.src='/content/hiv-db/NAVIFRAME/YELLOW/SearchDB.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/SearchDB.gif" BORDER=0 NAME="Searchdb"></A><BR>

<A HREF="/content/hiv-db/HTML/tools.html" 
	onMouseOver="document.Tools.src='/content/hiv-db/NAVIFRAME/YELLOW/_Tools.gif'"
	onMouseOut="document.Tools.src='/content/hiv-db/NAVIFRAME/YELLOW/Tools.gif'">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Tools.gif" BORDER=0 NAME="Tools"></A><BR>

<A HREF="/content/hiv-db/BASIC_BLAST/basic_blast.html" 
	onMouseOver="document.Hivblast.src='/content/hiv-db/NAVIFRAME/YELLOW/_HIV-BLAST.gif' "
	onMouseOut="document.Hivblast.src='/content/hiv-db/NAVIFRAME/YELLOW/HIV-BLAST.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/HIV-BLAST.gif" BORDER=0 NAME="Hivblast"></A><BR>

<A HREF="http://linker.lanl.gov/RIP/RIPsubmit.html" 
	onMouseOver="document.Rip.src='/content/hiv-db/NAVIFRAME/YELLOW/_Recombination.gif' "
	onMouseOut="document.Rip.src='/content/hiv-db/NAVIFRAME/YELLOW/Recombination.gif' " >
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Recombination.gif" BORDER=0 NAME="Rip"></A><BR>

<A HREF="/content/hiv-db/SNAP/WEBSNAP/SNAP.html" 
	onMouseOver="document.Snap.src='/content/hiv-db/NAVIFRAME/YELLOW/_Syn-Nonsyn.gif' "
	onMouseOut="document.Snap.src='/content/hiv-db/NAVIFRAME/YELLOW/Syn-Nonsyn.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Syn-Nonsyn.gif" BORDER=0 NAME="Snap"></A><BR>

<A HREF="/content/hiv-db/HYPERMUT/hypermut.html" 
	onMouseOver="document.Hypermut.src='/content/hiv-db/NAVIFRAME/YELLOW/_Hypermut.gif' "
	onMouseOut="document.Hypermut.src='/content/hiv-db/NAVIFRAME/YELLOW/Hypermut.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Hypermut.gif" BORDER=0 NAME="Hypermut"></A><BR>

<A HREF="/content/hiv-db/PCOORD/PCOORD.html" 
	onMouseOver="document.Pcoord.src='/content/hiv-db/NAVIFRAME/YELLOW/_PCOORD.gif' "
	onMouseOut="document.Pcoord.src='/content/hiv-db/NAVIFRAME/YELLOW/PCOORD.gif' " >
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/PCOORD.gif" BORDER=0 NAME="Pcoord"></A><BR>
    
<A HREF="/content/hiv-db/SUDI/sudi.html" 
	onMouseOver="document.SUDI.src='/content/hiv-db/NAVIFRAME/YELLOW/_SUDI.gif' "
	onMouseOut="document.SUDI.src='/content/hiv-db/NAVIFRAME/YELLOW/SUDI.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/SUDI.gif" BORDER=0 NAME="SUDI"></A><BR>

<A HREF="/content/hiv-db/CONTAM/TreeMaker/TreeMaker.html" 
	onMouseOver="document.Treemaker.src='/content/hiv-db/NAVIFRAME/YELLOW/_TreeMaker.gif' "
	onMouseOut="document.Treemaker.src='/content/hiv-db/NAVIFRAME/YELLOW/TreeMaker.gif' " >
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/TreeMaker.gif" BORDER=0 NAME="Treemaker"></A><BR>

<A HREF="/content/hiv-db/geography/map_right.html" 
	onMouseOver="document.Geography.src='/content/hiv-db/NAVIFRAME/YELLOW/_Geography.gif' "
	onMouseOut="document.Geography.src='/content/hiv-db/NAVIFRAME/YELLOW/Geography.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Geography.gif" BORDER=0 NAME="Geography"></A><BR>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/bottom.gif" BORDER=0></A><BR>

<!--
<br>
<small>
<small>
&nbsp;<a href="/content/hiv-db/combined_search/search">Combined Search</a>
</small>
</small>
</CENTER>
-->
<BR>
<BR>

<center>
<small>
<small>
<A HREF="http://www.lanl.gov/misc/disclaimer.html" >Disclaimer/Privacy</A>
</small>
</small>
<FONT FACE="Arial, Helvetica, sans-serif" SIZE="-2">
</FONT>
</center>

<!--
</BODY>
</HTML>
-->


        </td>
	<td>
	  <table border="0" cellspacing="0" cellpadding="3">
	    <tr><td>
            </td></tr>
	    <tr><td><html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage Express 2.0">
<title></title>
</head>

<body bgcolor="#FFFFFF">

<p align="center"><br>
<img src="../../../IMAGES/newtoplogo2.gif"> </p>

<p><font size="5"><strong>The Evolving Field of HIV CTL Epitope
Mapping: New Approaches to the Identification of Novel Epitopes </strong></font></p>

<p>Christian Brander1 and Philip J. R. Goulder1,2 </p>

<ol>
    <li>Partners AIDS Research Center, Massachusetts General
        Hospital, Boston, USA </li>
    <li>John Radcliffe Hospital, Oxford OX3 9DS, U.K. </li>
</ol>

<p>The past 12 months since the most recent update of the HIV CTL
epitope database have brought a large number of new or newly fine
mapped HIV protein derived CTL epitopes. In parallel, the
important role that CTL play in containing HIV and SIV
replication in the infected host has been supported further,
especially by viral escape studies in SIV infection. In addition,
the dependence of effective CTL activity on HIV specific T-helper
responses has become more evident, particularly from data
generated by recent treatment interruption studies. Other recent
studies have provided further strong evidence that T-helper
responses and the magnitude and breadth of CTL responses are
tightly linked. </p>

<p>In addition to these studies supporting earlier findings,
there have been significantly new directions established in the
field of anti-HIV T cell immunity. Once again the value of the
SIV animal model has been highlighted in the studies of Allen et
al., that identified epitopes within the Tat protein as being a
critical part of the apparently crucial acute CTL response
Allen00. This work drew attention to the disparity between CTL of
different specificities, so that CTL escape was observed in 100
of animals targeting the Mamu-A*01-restricted Tat epitope, but in
none of the same animals that also generated strong responses
towards the Mamu-A*01-restricted Gag epitope. Like the earlier
studies from this group, from other work in the lymphocytic
choriomeningitis virus (LCMV) animal model, and consistent with
data that have shown associations between particular HLA class I
alleles and rapid (for example HLA-B35) or slow progression (for
example, HLA-B57 or B27) in HIV infection, these studies
underlined that CTL of different specificities are not equal.
Moreover, the CTL specificities that may characterize chronic
infection may not actually be those that are important in
considerations of vaccine development as some recent data suggest
that the specificities of CTL responses observed in chronic
responses can differ form those in the acute phase of infection.
This is for instance the case for the HLA-A*0201-restricted
response to the SL9 epitope in p17 Gag. This is the best-studied
CTL specificity in HIV infection, is detectable in 75 of adults
expressing A*0201 in chronic infection, and yet was not
detectable in 11 A*0201-positive adults studied during acute
infection (most prior to seroconversion) Goulder01b. </p>

<p>The focus of HIV CTL studies has therefore increasingly turned
to characterizing the timing and specificities of the acute CTL
response, since this is very likely to significantly contribute
to the initial reduction in viremia and in determining the
eventual steady-state set-point during chronic infection. This
increased appreciation of the importance of the acute CTL
response has brought the realization that the CTL response must
be more comprehensively screened, and restricting the analyses to
the well-studied proteins of Gag, Nef, RT and Env may not be
adequate. Novel technologies such as intracellular cytokine
stainings and Elispot assays to detect antigen specific T cells
(see below) now make it possible to screen for responses using
hundreds of overlapping peptides that span all the HIV proteins.
Although this is expensive, this approach may be necessary in
order to obtain a comprehensive view of the all-important early
CTL response. </p>

<p><b>New methods for the accurate measurement of CTL responses</b>
</p>

<p>Many of the above mentioned exiting new results were obtained
by applying new technologies that facilitate the detection of CTL
and Th responses Kaul99. Also, these newer approaches have
detected immune responses with a higher sensitivity, allowing the
complete breadth of CTL responses to be monitored. Elispot assays
combined with intracellular staining (ICS) for Interferon (IFN-)
allow for the screening of the entire protein sequences of HIV
for T cell mediated immune responses and to determine the
phenotype of the responding cells. Importantly, this also allows
for functional analyses of antigen specific cells, including
intracelluar perforin and cytokine contents. However, no real
alternative to fresh killing (ex-vivo) assays has been developed
at this point. </p>

<p>Elispot and ICS have proven useful for epitope fine mapping
and definition of HLA restriction without the cumbersome
generation of CTL clones and lines. However, analyses using
polyclonal PBMC preparation may be inconclusive if different
epitopes overlap within the tested peptide and if overlapping
epitopes can be presented by different HLA class I molecules.
These potential limitations should be kept in mind if epitope
fine mapping and HLA restriction analyses are carried out using
PBMC preparation. These considerations also affect the criteria
we would like to set forward for epitope inclusion in this
section of ``optimal epitopes'' within the database, especially
with regard to the identification of the restricting HLA class I
molecules (see below). </p>

<p><b>Novel CTL epitopes: Immunodominance and Effectiveness</b> </p>

<p>While the new technologies have greatly increased the speed
with which novel epitopes can be defined, from the foregoing
discussions it is clearer than before that mere descriptions of
new epitopes are only a first step, albeit an important one, in
understanding the role of specific CTL responses in control of
HIV. Epitope identification has greater value when placed in the
context of the individual subjects and of the population being
studied. Thus, it is important to know the proportion of
HIV-infected individuals expressing the appropriate HLA type who
make the CTL response, to know the magnitude of the response in
relation to other HIV-specific CTL responses, and to know the
timing of the response (acute/chronic), and the viral load of the
subject. Determining the effectiveness of individual CTL
specificities is not straightforward, but the ability to link a
reliably dominant response, generated in acute infection, to
long-term control of HIV replication (i.e., low viral load) would
be of value in consideration of vaccine design. </p>

<p><b>Epitope prediction</b> </p>

<p>The ``reverse immunogenetics'' approach to define novel CTL
epitopes has been an enormously successful one, rapidly achieving
the desired result of the equivalent of finding a needle in a
haystack. The elution of peptides from individual class I
molecules has generated a huge amount of valuable data regarding
the types of peptides that are best-suited for binding to
particular class I molecules. Using these peptide-binding motifs
to synthesize new peptides that can be tested for binding and for
CTL recognition is therefore an attractive method that is
continually being refined (SYFPEITHI, Database of MHC ligands and
peptide motifs; http://www.uni- tuebingen.de/uni/kxi). Combining
the reverse immunogenetics and the comprehensive screening
methods may today be the most effective approach to quickly reach
the optimal epitopes prediction from a 15mer peptide sequence.
Having arrived at this putative optimal peptide, confirmation
using 4 additional peptides (with one amino acid added or
truncated from each terminus of the predicted optimal peptide)
will define the optimal epitope sequence with minimal synthesis
of truncated peptides. </p>

<p><b>New viral targets and epitope clustering</b> </p>

<p>Newly identified epitopes that have been reported since the
last update of this database confirm previously observed trends.
One trend is that an increasing number of CTL epitopes are being
identified in proteins outside the traditionally well studied HIV
proteins Gag, RT, Env and Nef. This is greatly due to the use of
the above described new methodologies that have allowed more
sensitive and comprehensive studies of proteins previously not
analyzed, especially Tat, Rev and Vpr. Interestingly, a recent
report showed that Tat may be targeted frequently in acute
infection and may contribute to the containment of the initial
viremia, although early escape form these responses was observed
Allen00. Similarly, more CTL responses to Rev have been reported
recently and may prove useful with regard to vaccine design. It
will be important to investigate whether early expression of
these proteins (especially before Nef mediated downregulation of
HLA class I may take place) could lead to rapid elimination of
infected cells resulting in diminished viral burst size. </p>

<p>Another trend that has been confirmed by newly identified
epitopes is the clustering of epitopes in certain regions of the
different HIV proteins. Recently published work now shows that
such epitope clustering is maintained even in individuals with
HLA backgrounds that have not traditionally been well studied
Goulder00c. However, one recent study found that the
immunodominant HIV Gag response in Caucasians was more often
targeting an epitope in Gag p17, whereas in Africans, the
immunodominant response mapped more frequently to an epitope in
Gag p24 Goulder00c. </p>

<p>The likely basis for these differences is the identity of the
HLA class I molecules prevalent in the different populations. In
addition, alternative mechanisms such as race-dependent
differences in the unfolding of HIV proteins and proteasomal
digestion and differences in T cell repertoire and available HLA
class I alleles to bind and present the processed epitopes may
contribute to the different clustering. Finally, sequence
differences between HIV clade B and clade C may be a constraining
factor for the presentation of immunogenic peptides. Further
characterization of HIV specific CTL responses and the fine
mapping of these responses in non-Caucasian individuals and
individuals infected with non-clade B virus will be necessary to
identify the major factors leading to the observed differences in
epitope clustering. Importantly, a better understanding of these
factors will also be required for the design of population
tailored vaccine. </p>

<p><b>HLA restriction analyses and HLA-C alleles</b> </p>

<p>In the past, some epitopes have been excluded form the list of
``optimal CTL epitopes'' based on inconclusive data on HLA
restriction of these epitopes, often caused by high degrees of
linkage disequilibrium between certain alleles and the presence
of allele subtypes. Some of these epitopes have been reinstated
in this list as more HLA restriction analyses data were provided.
Since the problem of inconclusive HLA restriction analyses will
persist in the future, especially when investigations move into
less well characterized ethnicities where the available data of
crosspresentation and existence of sub-alleles is limited, it
appears important to perform these analyses carefully and with
the best available tools. The use of single HLA class I allele
transfected cell lines appears as the gold standard for these
analyses, provided the correct allele subtype is used (if
subtypes are known at all). We would thus like to encourage
investigators that have generated such cell lines or face these
kind of problems to share their reagents with other investigators
for a faster and more accurate characterization of newly
discovered CTL epitopes. </p>

<p>The last year has also confirmed the trend that HLA-C alleles
can present a number of HIV derived epitopes. This is especially
important as HIV Nef does not appear to downregulate C alleles
and responses restricted by HLA C may thus not be subject to this
immune modulating effect. However, Nef mediated downregulation of
HLA class I does not appear to become effective until relatively
late in the viral replication cycle and the numbers of HLA-C
alleles on the cell surface is low compared to HLA-A and -B
alleles. Therefore, the importance of HLA-C alleles restricted
CTL responses in HIV infection remains to be established. </p>

<p>As every year, we would like to express our gratitude to the
large number of researchers in the field who continuously
contribute to this database. We very much welcome any criticism,
comments and additions to this list since we are sure that some
epitopes will unintentionally escape our attention, despite close
monitoring of the literature. Also, pertinent information, such
as resources for single HLA allele expressing cell lines, HLA
subtype information and new technologies for CTL epitope mapping
could be listed or referenced in this list, providing additional
help to problems encountered by investigators. Please write or
call us with any comments you may have. </p>

<p><b>Best defined epitope table</b> </p>

<p>In the table that follows, primary anchors are bold faced,
secondary anchors are not. The amino acid position numbers shown
are those of the analagous epitope in HXB2R, our standard strain
as used in other parts of this database. </p>

<table border="1" cellpadding="4" spacing="2">
    <tr>
        <td>Christian Brander<br>
        phone: (617) 724-5789<br>
        FAX: (617) 726-5411<br>
        brander@helix.mgh.harvard.edu </td>
        <td>Philip J. R. Goulder<br>
        phone: (617) 726-5787 or 01144-1865-221335<br>
        FAX: (617) 726-5411<br>
        goulder@helix.mgh.harvard.edu </td>
    </tr>
    <tr>
        <td>Bruce D. Walker<br>
        phone: (617) 724-8332<br>
        FAX: (617) 726-4691<br>
        bwalker@helix.mgh.harvard.edu </td>
        <td>Bette Korber<br>
        phone: (505) 665-4453<br>
        FAX: (505) 665-3493<br>
        btk@t10.lanl.gov </td>
    </tr>
</table>

<p><strong>Table 1 Best Defined HIV CTL Epitopes </strong></p>

<table border="1" cellpadding="9" cellspacing="1" width="100%">
    <tr>
        <td>HLA</td>
        <td>Protein</td>
        <td>AA</td>
        <td>Sequence </td>
        <td>Reference</td>
    </tr>
    <tr>
        <td>A*0201 (A2)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2   6  C</pre>
        </td>
        <td>Falk91,Barouch95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>1 anchor</td>
        <td align="right"><pre><b>L      L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>M      V</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>2 anchor</td>
        <td align="right"><pre>V   </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>77--85</td>
        <td align="right"><pre>SLYNTVATL</pre>
        </td>
        <td>Johnson91,Parker92,Parker94</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>33--41</td>
        <td align="right"><pre>ALVEICTEM</pre>
        </td>
        <td>Haas98,HaasPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>179--187</td>
        <td align="right"><pre>VIYQYMDDL</pre>
        </td>
        <td>Harrer96a</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>309--317</td>
        <td align="right"><pre>ILKEPVHGV</pre>
        </td>
        <td>Walker89,Tsomides91</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>311--320</td>
        <td align="right"><pre>RGPGRAFVTI</pre>
        </td>
        <td>Alexander-Miller96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>813--822</td>
        <td align="right"><pre>SLLNATDIAV</pre>
        </td>
        <td>Dupuis95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>136--145</td>
        <td align="right"><pre>PLTFGWCYKL</pre>
        </td>
        <td>Haas96,MaierAutranPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>180--189</td>
        <td align="right"><pre>VLEWRFDSRL</pre>
        </td>
        <td>Haas96,MaierAutranPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Vpr</td>
        <td>58--66</td>
        <td align="right"><pre>AIIRILQQL</pre>
        </td>
        <td>Altfeld01</td>
    </tr>
    <tr>
        <td>A*0202 (A2)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>Barouch95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>L      L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>V</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>77--85</td>
        <td align="right"><pre>SLYNTVATL</pre>
        </td>
        <td>GoulderPerCom00</td>
    </tr>
    <tr>
        <td>A*0205 (A2)</td>
        <td>p17</td>
        <td>77--85</td>
        <td align="right"><pre>SLYNTVATL</pre>
        </td>
        <td>GoulderPerCom00</td>
    </tr>
    <tr>
        <td>A*0301 (A3)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>DiBrino93,Rammensee95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>L      K</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>V      Y</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>M      F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>18--26</td>
        <td align="right"><pre>KIRLRPGGK</pre>
        </td>
        <td>Harrer96b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>20--28</td>
        <td align="right"><pre>RLRPGGKKK</pre>
        </td>
        <td>Goulder97, CulmannPerCom99, LewinsohnRiddellPerCom99,
        WilkesRuhlPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>20--29</td>
        <td align="right"><pre>RLRPGGKKKY</pre>
        </td>
        <td>Goulder00b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>33--43</td>
        <td align="right"><pre>ALVEICTEMEK</pre>
        </td>
        <td>Haas98,HaasPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>93--101</td>
        <td align="right"><pre>GIPHPAGLK</pre>
        </td>
        <td>Altfeld00c</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>158--166</td>
        <td align="right"><pre>AIFQSSMTK</pre>
        </td>
        <td>Threlkeld97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>269--277</td>
        <td align="right"><pre>QIYPGIKVR</pre>
        </td>
        <td>Altfeld00c</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>VIF</td>
        <td>17--26</td>
        <td align="right"><pre>RIRTWKSLVK</pre>
        </td>
        <td>Altfeld00c</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>37--46</td>
        <td align="right"><pre>TVYYGVPVWK</pre>
        </td>
        <td>Johnson94</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>770--780</td>
        <td align="right"><pre>RLRDLLLIVTR</pre>
        </td>
        <td>Takahashi91</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>73--82</td>
        <td align="right"><pre>QVPLRPMTYK</pre>
        </td>
        <td>Koenig90,Culmann91</td>
    </tr>
    <tr>
        <td>A*1101 (A11)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>Zhang93,Rammensee95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>K</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>V      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>I      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>F      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>Y      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>84--92</td>
        <td align="right"><pre>TLYCVHQRI</pre>
        </td>
        <td>Harrer98</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>217--227</td>
        <td align="right"><pre>ACQGVGGPGHK</pre>
        </td>
        <td>Sipsas97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>158--166</td>
        <td align="right"><pre>AIFQSSMTK</pre>
        </td>
        <td>Johnson94b,Zhang93,Threlkeld97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>341--350</td>
        <td align="right"><pre>IYQEPFKNLK</pre>
        </td>
        <td>CulmannPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>520--528</td>
        <td align="right"><pre>QIIEQLIKK</pre>
        </td>
        <td>Fukada99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Integrase</td>
        <td>179--188</td>
        <td align="right"><pre>AVFIHNFKRK</pre>
        </td>
        <td>Fukada99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>73--82</td>
        <td align="right"><pre>QVPLRPMTYK</pre>
        </td>
        <td>BuseynePerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>75--82</td>
        <td align="right"><pre>PLRPMTYK</pre>
        </td>
        <td>Culmann91</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>84--92</td>
        <td align="right"><pre>AVDLSHFLK</pre>
        </td>
        <td>Culmann91</td>
    </tr>
    <tr>
        <td>A*2402 (A24)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>Maier94</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>Y      I</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>28--36</td>
        <td align="right"><pre>KYKLKHIVW</pre>
        </td>
        <td>IkedaMoore98, LewinsohnPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>162--172</td>
        <td align="right"><pre>RDYVDRFFKTL</pre>
        </td>
        <td>Dorrell99, Rowland-JonesPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>52--61</td>
        <td align="right"><pre>LFCASDAKAY</pre>
        </td>
        <td>Lieberman92,Shankar96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>585--593</td>
        <td align="right"><pre>RYLKDQQLL</pre>
        </td>
        <td>Dai92</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>134--141</td>
        <td align="right"><pre>RYPLTFGW</pre>
        </td>
        <td>Goulder97f,IkedaMoore98</td>
    </tr>
    <tr>
        <td>A*2501 (A25)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>13--23</td>
        <td align="right"><pre>QAISPRTLNAW</pre>
        </td>
        <td>KuraneWestPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>71--80</td>
        <td align="right"><pre>ETINEEAAEW</pre>
        </td>
        <td>Klenerman96,vanBaalen96</td>
    </tr>
    <tr>
        <td>A*2601 (A26)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>12   6  C</pre>
        </td>
        <td>Dumrese98</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>V      Y</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>T      F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>I       </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>L       </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>F       </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>D    I   </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>E    L   </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>V   </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>35--43</td>
        <td align="right"><pre>EVIPMFSAL</pre>
        </td>
        <td>Goulder96b</td>
    </tr>
    <tr>
        <td>A*2902 (A29)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>209--217</td>
        <td align="right"><pre>SFEPIPIHY</pre>
        </td>
        <td>Altfeld00c</td>
    </tr>
    <tr>
        <td>A*3002 (A30)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>12        C</pre>
        </td>
        <td>Rammensee99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>Y        Y</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>F         </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>L         </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>V         </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>R         </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>76--86</td>
        <td align="right"><pre>RSLYNTVATLY</pre>
        </td>
        <td>Goulder01a</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>173--181</td>
        <td align="right"><pre>KQNPDIVIY</pre>
        </td>
        <td>Goulder01a</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>263--271</td>
        <td align="right"><pre>KLNWASQIY</pre>
        </td>
        <td>Goulder01a</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>704--712</td>
        <td align="right"><pre>IVNRNRQGY</pre>
        </td>
        <td>Goulder01a</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp41</td>
        <td>794--802</td>
        <td align="right"><pre>KYCWNLLQY</pre>
        </td>
        <td>Goulder01a</td>
    </tr>
    <tr>
        <td>A*3101 (A31)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2        C</pre>
        </td>
        <td>Falk94,Rammensee99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>R</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>L         </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>V         </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>Y         </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>F         </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>770--780</td>
        <td align="right"><pre>RLRDLLLIVTR</pre>
        </td>
        <td>Safrit94a,Safrit94b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>A*3201 (A32)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>392--401</td>
        <td align="right"><pre>PIQKETWETW</pre>
        </td>
        <td>Harrer96b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>419--427</td>
        <td align="right"><pre>RIKQIINMW</pre>
        </td>
        <td>Harrer96b</td>
    </tr>
    <tr>
        <td>A*6802 (A68)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Protease</td>
        <td>3--11</td>
        <td align="right"><pre>ITLWQRPLV</pre>
        </td>
        <td>Rowland-JonesPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Protease</td>
        <td>30--38</td>
        <td align="right"><pre>DTVLEEWNL</pre>
        </td>
        <td>Rowland-JonesPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>777--785</td>
        <td align="right"><pre>IVTRIVELL</pre>
        </td>
        <td>WilkesPerCom99*</td>
    </tr>
    <tr>
        <td>A*7401 (A19)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Protease</td>
        <td>3--11</td>
        <td align="right"><pre>ITLWQRPLV</pre>
        </td>
        <td>Rowland-JonesPerCom99</td>
    </tr>
    <tr>
        <td>B*0702 (B7)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>123     C</pre>
        </td>
        <td>Englehard93,Rammensee99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>P       L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>A R      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>R K      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>16--24</td>
        <td align="right"><pre>SPRTLNAWV</pre>
        </td>
        <td>LewinsohnPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>48--56</td>
        <td align="right"><pre>TPQDLNTML</pre>
        </td>
        <td>Wilson99a, WilkesRuhlGoulderPerCom99, Jin00, Wilson97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>223--231</td>
        <td align="right"><pre>GPGHKARVL</pre>
        </td>
        <td>GoulderPerCom00</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>298--307</td>
        <td align="right"><pre>RPNNNTRKSI</pre>
        </td>
        <td>Safrit94b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>843--851</td>
        <td align="right"><pre>IPRRIRQGL</pre>
        </td>
        <td>WilkesRuhlPerCom99*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>68--77</td>
        <td align="right"><pre>FPVTPQVPLR</pre>
        </td>
        <td>Haas96, MaierAutranPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>71--79</td>
        <td align="right"><pre>TPQVPLRPM</pre>
        </td>
        <td>GoulderPerCom99*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>77--85</td>
        <td align="right"><pre>RPMTYKAAL</pre>
        </td>
        <td>Bauer97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>106--115</td>
        <td align="right"><pre>RQDILDLWIY</pre>
        </td>
        <td>GoulderPerCom00</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>128--137</td>
        <td align="right"><pre>TPGPGVRYPL</pre>
        </td>
        <td>CulmannPenciolelli94, Haas96</td>
    </tr>
    <tr>
        <td>B*0801 (B8)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>23 5   C</pre>
        </td>
        <td>Hill92b,Sutton93, DiBrino94b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>K K   L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>R    </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>PR      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>L       </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>24--32</td>
        <td align="right"><pre>GGKKKYKLK</pre>
        </td>
        <td>RowlandJones93a, Goulder97c</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>74--82</td>
        <td align="right"><pre>ELRSLYNTV</pre>
        </td>
        <td>Goulder97c</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>128--135</td>
        <td align="right"><pre>EIYKRWII</pre>
        </td>
        <td>Sutton93, Goulder97c</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>197--205</td>
        <td align="right"><pre>DCKTILKAL</pre>
        </td>
        <td>Sutton93</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>18--26</td>
        <td align="right"><pre>GPKVKQWPL</pre>
        </td>
        <td>Walker89, Sutton93</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>2--10</td>
        <td align="right"><pre>RVKEKYQHL</pre>
        </td>
        <td>Sipsas97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>586--593</td>
        <td align="right"><pre>YLKDQQLL</pre>
        </td>
        <td>Johnson92,Shankar96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>13--20</td>
        <td align="right"><pre>WPTVRERM</pre>
        </td>
        <td>Goulder97c</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>90--97</td>
        <td align="right"><pre>FLKEKGGL</pre>
        </td>
        <td>CulmannPenciolelli94,Price97</td>
    </tr>
    <tr>
        <td>?B*1401 or B*1402 (B14)</td>
        <td>Rev</td>
        <td>67--75</td>
        <td align="right"><pre>SAEPVPLQL</pre>
        </td>
        <td>vanBaalenPerCom00</td>
    </tr>
    <tr>
        <td>B*1402 (B14)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>23 5   C</pre>
        </td>
        <td>DiBrino94a</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>R  R   L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>K  H    </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>L      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>Y      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>F      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>166--174</td>
        <td align="right"><pre>DRFYKTLRA</pre>
        </td>
        <td>Harrer96b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>584--592</td>
        <td align="right"><pre>ERYLKDQQL</pre>
        </td>
        <td>Johnson92</td>
    </tr>
    <tr>
        <td>B*1501 (B62)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>Q      Y</b></pre>
        </td>
        <td>Barber97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>L      F</b></pre>
        </td>
        <td>Barber97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>M       </b></pre>
        </td>
        <td>Barber97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>137--145</td>
        <td align="right"><pre>GLNKIVRMY</pre>
        </td>
        <td>Johnson91,GoulderPerCom99*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>260--271</td>
        <td align="right"><pre>LVGKLNWASQIY</pre>
        </td>
        <td>JohnsonPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>309--318</td>
        <td align="right"><pre>ILKEPVHGVY</pre>
        </td>
        <td>Johnson91,JohnsonPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>117--127</td>
        <td align="right"><pre>TQGYFPDWQNY</pre>
        </td>
        <td>CulmannPerCom99</td>
    </tr>
    <tr>
        <td>B*1516 (B63)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      9</pre>
        </td>
        <td>Barber97,Seeger98</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>T      Y</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>S      I</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>V</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>375--383</td>
        <td align="right"><pre>SFNCGGEFF</pre>
        </td>
        <td>Wilson97,WilsonPerCom99</td>
    </tr>
    <tr>
        <td>B*1801 (B18)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>161--170</td>
        <td align="right"><pre>FRDYVDRFYK</pre>
        </td>
        <td>Ogg98</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>135--143</td>
        <td align="right"><pre>YPLTFGWCY</pre>
        </td>
        <td>Culmann91,CulmannPenciolelli94</td>
    </tr>
    <tr>
        <td>B*2703 (B27)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>131--140</td>
        <td align="right"><pre>RRWIQLGLQK</pre>
        </td>
        <td>Rowland-Jones98, Rowland-JonesPerCom99</td>
    </tr>
    <tr>
        <td>B*2705 (B27)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>12       C</pre>
        </td>
        <td>Jardetzky91,Rammensee95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>R       L</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>K        K</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>R        R</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>G        I</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>A         </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>19--27</td>
        <td align="right"><pre>IRLRPGGKK</pre>
        </td>
        <td>McKinney99,LewinsohnPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>131--140</td>
        <td align="right"><pre>KRWIILGLNK</pre>
        </td>
        <td>Nixon88,Buseyne93,Goulder97b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>786--795</td>
        <td align="right"><pre>GRRGWEALKY</pre>
        </td>
        <td>Lieberman92,LiebermanPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>105--114</td>
        <td align="right"><pre>RRQDILDLWI</pre>
        </td>
        <td>Goulder97</td>
    </tr>
    <tr>
        <td>B*3501 (B35)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>Hill92b,Rammensee99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>P      Y</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>A      F</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>V      M</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>S      L</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>I</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>36--44</td>
        <td align="right"><pre>WASRELERF</pre>
        </td>
        <td>Goulder97f</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>124--132</td>
        <td align="right"><pre>NSSKVSQNY</pre>
        </td>
        <td>RowlandJones95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>122--130</td>
        <td align="right"><pre>PPIPVGDIY</pre>
        </td>
        <td>RowlandJones95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>122--130</td>
        <td align="right"><pre>NPVPVGNIY</pre>
        </td>
        <td>RowlandJones95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>107--115</td>
        <td align="right"><pre>TVLDVGDAY</pre>
        </td>
        <td>Wilson99a,WilkesRuhlPerCom99,</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>118--127</td>
        <td align="right"><pre>VPLDEDFRKY</pre>
        </td>
        <td>Sipsas97,Shiga96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>175--183</td>
        <td align="right"><pre>NPDIVIYQY</pre>
        </td>
        <td>Sipsas97,Shiga96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>175--183</td>
        <td align="right"><pre>HPDIVIYQY</pre>
        </td>
        <td>RowlandJones95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>42--52</td>
        <td align="right"><pre>VPVWKEATTTL</pre>
        </td>
        <td>WilkesRuhlPerCom99*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>78--86</td>
        <td align="right"><pre>DPNPQEVVL</pre>
        </td>
        <td>Shiga96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>606--614</td>
        <td align="right"><pre>TAVPWNASW</pre>
        </td>
        <td>Johnson94</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>74--81</td>
        <td align="right"><pre>VPLRPMTY</pre>
        </td>
        <td>Culmann91,CulmannPenciolelli94</td>
    </tr>
    <tr>
        <td>B*3701 (B37)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>Falk93</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>D      F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>E      M</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>I</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>B*3701 (B37)</td>
        <td>Nef</td>
        <td>120--128</td>
        <td align="right"><pre>YFPDWQNYT</pre>
        </td>
        <td>Culmann91,CulmannPerCom99</td>
    </tr>
    <tr>
        <td>B*3901 (B39)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>Falk95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>R      L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>H       </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>B*3901 (B39)</td>
        <td>p24</td>
        <td>61--69</td>
        <td align="right"><pre>GHQAAMQML</pre>
        </td>
        <td>KuraneWestPerCom99</td>
    </tr>
    <tr>
        <td>B*4001 (B60)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>Falk95a</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>E      L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p17</td>
        <td>92--101</td>
        <td align="right"><pre>IEIKDTKEAL</pre>
        </td>
        <td>Altfeld00*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>44--52</td>
        <td align="right"><pre>SEGATPQDL</pre>
        </td>
        <td>Altfeld00*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p2p7p1p6</td>
        <td>118--126</td>
        <td align="right"><pre>KELYPLTSL</pre>
        </td>
        <td>YuPerCom01</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>202--210</td>
        <td align="right"><pre>IEELRQHLL</pre>
        </td>
        <td>Altfeld00*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>805--814</td>
        <td align="right"><pre>QELKNSAVSL</pre>
        </td>
        <td>Altfeld00*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>92--100</td>
        <td align="right"><pre>KEKGGLEGL</pre>
        </td>
        <td>Altfeld00*</td>
    </tr>
    <tr>
        <td>B*4201 (B42)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>48--56</td>
        <td align="right"><pre>TPQDLNTML</pre>
        </td>
        <td>Goulder00c</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>271--279</td>
        <td align="right"><pre>YPGIKVRQL</pre>
        </td>
        <td>WilkesRuhlPerCom99*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>128--137</td>
        <td align="right"><pre>TPGPGVRYPL</pre>
        </td>
        <td>GoulderPerCom99*</td>
    </tr>
    <tr>
        <td>B*4402 (B44)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2        C</pre>
        </td>
        <td>Rammensee99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>E        F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>Y</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>162--172</td>
        <td align="right"><pre>RDYVDRFYKTL</pre>
        </td>
        <td>Ogg98</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>174--184</td>
        <td align="right"><pre>AEQASQDVKNW</pre>
        </td>
        <td>LewinsohnPerCom99*</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>31--40</td>
        <td align="right"><pre>AENLWVTVYY</pre>
        </td>
        <td>Borrow97</td>
    </tr>
    <tr>
        <td>B*5101 (B51)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>Falk95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>A      F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>P      I</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>G       </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>42--50</td>
        <td align="right"><pre>EKEGKISKI</pre>
        </td>
        <td>Haas98,HaasPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>128--135</td>
        <td align="right"><pre>TAFTIPSI</pre>
        </td>
        <td>Sipsas97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>416--424</td>
        <td align="right"><pre>LPCRIKQII</pre>
        </td>
        <td>Tomiyama99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>557--565</td>
        <td align="right"><pre>RAIEAQQHL</pre>
        </td>
        <td>Sipsas97</td>
    </tr>
    <tr>
        <td>B*5201 (B52)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2     C</pre>
        </td>
        <td>Rammensee99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>I</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>V</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>Q      </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>143--150</td>
        <td align="right"><pre>RMYSPTSI</pre>
        </td>
        <td>WilkesRuhlPerCom99,Wilson97</td>
    </tr>
    <tr>
        <td>B*5301 (B53)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2      C</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>P      L</b></pre>
        </td>
        <td>Hill92b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>48--56</td>
        <td align="right"><pre>TPYDINQML</pre>
        </td>
        <td>Gotch93</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>176--184</td>
        <td align="right"><pre>QASQEVKNW</pre>
        </td>
        <td>Buseyne96, Buseyne97, BuseynePerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Tat</td>
        <td>2--11</td>
        <td align="right"><pre>EPVDPRLEPW</pre>
        </td>
        <td>Addo00</td>
    </tr>
    <tr>
        <td>B*5501 (B55)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2       C</pre>
        </td>
        <td>Barber95</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>P        </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>A</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>42--51</td>
        <td align="right"><pre>VPVWKEATTT</pre>
        </td>
        <td>Shankar96,LiebermanPerCom99</td>
    </tr>
    <tr>
        <td>B*5701 (B57)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>12      C</pre>
        </td>
        <td>Barber97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>A      F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>T      W</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>S       </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>K       Y</pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>15--23</td>
        <td align="right"><pre>ISPRTLNAW</pre>
        </td>
        <td>Johnson91,Goulder96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>30--40</td>
        <td align="right"><pre>KAFSPEVIPMF</pre>
        </td>
        <td>Goulder96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>108--118</td>
        <td align="right"><pre>TSTLQEQIGWF</pre>
        </td>
        <td>Goulder96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>176--184</td>
        <td align="right"><pre>QASQEVKNW</pre>
        </td>
        <td>Goulder96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>RT</td>
        <td>244--252</td>
        <td align="right"><pre>IVLPEKDSW</pre>
        </td>
        <td>vanderBurg97,HayPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Integrase</td>
        <td>173--181</td>
        <td align="right"><pre>KTAVQMAVF</pre>
        </td>
        <td>Goulder96,HayPerCom99</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Rev</td>
        <td>14--23</td>
        <td align="right"><pre>KAVRLIKFLY</pre>
        </td>
        <td>AddoPerCom01</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>116--125</td>
        <td align="right"><pre>HTQGYFPDWQ</pre>
        </td>
        <td>Culmann91</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>120--128</td>
        <td align="right"><pre>YFPDWQNYT</pre>
        </td>
        <td>Culmann91</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>B*5703 (B57)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>30--37</td>
        <td align="right"><pre>KAFSPEVI</pre>
        </td>
        <td>Goulder00b</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>30--40</td>
        <td align="right"><pre>KAFSPEVIPMF</pre>
        </td>
        <td>Goulder00b</td>
    </tr>
    <tr>
        <td>B*5801 (B58)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>12       C</pre>
        </td>
        <td>Barber97,Falk95a</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>A       F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>T       W</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>S        </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>K         </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>V         </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>I         </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>108--117</td>
        <td align="right"><pre>TSTVEEQQIW</pre>
        </td>
        <td>Bertoletti98</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>108--117</td>
        <td align="right"><pre>TSTLQEQIGW</pre>
        </td>
        <td>Goulder96</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Rev</td>
        <td>14--23</td>
        <td align="right"><pre>KAVRLIKFLY</pre>
        </td>
        <td>Addo00</td>
    </tr>
    <tr>
        <td>B*8101 (B81)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>48--56</td>
        <td align="right"><pre>TPQDLNTML</pre>
        </td>
        <td>Goulder00c</td>
    </tr>
    <tr>
        <td>C*0102 (Cw1)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>23    C</pre>
        </td>
        <td>Barber97</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>A    L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>L     </b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>P    </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>36--43</td>
        <td align="right"><pre>VIPMFSAL</pre>
        </td>
        <td>Goulder97f</td>
    </tr>
    <tr>
        <td>C*0401 (Cw4)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>2   6  C</pre>
        </td>
        <td>Falk94</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>Y      L</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>P      F</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre><b>F      M</b></pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>V   </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>I   </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td align="right"><pre>L   </pre>
        </td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>gp160</td>
        <td>375--383</td>
        <td align="right"><pre>SFNCGGEFF</pre>
        </td>
        <td>Wilson97,Johnson93</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>176--184</td>
        <td align="right"><pre>QASQEVKNW</pre>
        </td>
        <td>Buseyne97,BuseynePerCom99</td>
    </tr>
    <tr>
        <td>Cw*0501 (Cw5)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Rev</td>
        <td>67--75</td>
        <td align="right"><pre>SAEPVPLQL</pre>
        </td>
        <td>Addo00</td>
    </tr>
    <tr>
        <td>C*0802 (Cw8)</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>p24</td>
        <td>48--56</td>
        <td align="right"><pre>TPQDLNTML</pre>
        </td>
        <td>Goulder00c</td>
    </tr>
    <tr>
        <td>&nbsp;</td>
        <td>Nef</td>
        <td>82--91</td>
        <td align="right"><pre>KAAVDLSHFL</pre>
        </td>
        <td>Nixon99</td>
    </tr>
</table>

<p>* indicates personal communications in which
truncation/titration data was provided subtype of B57 not
determined </p>

<p>Primary anchors are bold faced, secondary anchors are not. </p>

<p>The amino acid position numbers are those of the analagous
epitope in HXB2R our standard strain as used in other parts of
this database. </p>

<p><strong>REFERENCES </strong></p>

<ol>
    <li><b>[AddoPerCom01</b>] M. Addo. personal communication.
        unpublished 2001. </li>
    <li><b>[Addo00</b>] M.M. Addo, M. Altfeld, E.S. Rosenberg,
        &amp; et al. The HIV-1 regulatory proteins Tat and Rev
        are freqently targeted by cytotoxic T lymphocyte (CTL)
        derived from HIV infected individuals. <i>Proc.Natl.Acad.Sci.</i>
        in press 2001. </li>
    <li><b>[Alexander-Miller (1996)</b>] Alexander-Miller96 M. A.
        Alexander-Miller, K. C. Parker, T. Tsukui, C. D.
        Pendleton, J. E. Coligan, J. A. Berzofsky. Molecular
        analysis of presentation by HLA-A2.1 of a promiscuously
        binding V3 loop peptide from the HIV-1 Envelope protein
        to human cytotoxic T lymphocytes. <em>Int Immunol</em> <em><strong>8</strong></em>:641--649,
        1996. </li>
    <li><b>[Allen (2000)</b>] Allen00 T. M. Allen, D. H.
        O'Connor, P. Jing, J. L. Dzuris, B. R. Mothe, T. U.
        Vogel, E. Dunphy, M. E. Liebl, C. Emerson, N. Wilson, K.
        J. Kunstman, X. Wang, D. B. Allison, A. L. Hughes, R. C.
        Desrosiers, J. D. Altman, S. M. Wolinsky, A. Sette, D. I.
        Watkins. Tat-specific cytotoxic T lymphocytes select for
        SIV escape variants during resolution of primary viraemia
        <b>[see comments</b>] . <em>Nature</em> <strong>407</strong>:386--90,
        2000. </li>
    <li><b>[Altfeld (2000)</b>] Altfeld00c M. Altfeld . Personal
        communication. unpublished 2000. </li>
    <li><b>[Altfeld (2001)</b>] Altfeld01 M. A. Altfeld, B.
        Livingston, N. Reshamwala, P. T. Nguyen, M. M. Addo, A.
        Shea, M. Newman, J. Fikes, J. Sidney, P. Wentworth, R.
        Chesnut, R. L. Eldridge, E. S. Rosenberg, G. K. Robbins,
        C. Brander, P. E. Sax, S. Boswell, T. Flynn, S.
        Buchbinder, P. J. Goulder, B. D. Walker, A. Sette, S. A.
        Kalams. Identification of Novel HLA-A2-Restricted Human
        Immunodeficiency Virus Type 1-Specific Cytotoxic
        T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype
        Peptide-Binding Motif. <em>J Virol</em> <strong>75</strong>:1301--1311,
        2001. </li>
    <li><b>[Altfeld (2000)</b>] Altfeld00 M. A. Altfeld, A.
        Trocha, R. L. Eldridge, E. S. Rosenberg, M. N. Phillips,
        M. M. Addo, R. P. Sekaly, S. A. Kalams, S. A. Burchett,
        K. McIntosh, B. D. Walker, P. J. Goulder. Identification
        of dominant optimal HLA-B60- and HLA-B61-restricted
        cytotoxic T-lymphocyte (CTL) epitopes: rapid
        characterization of CTL responses by enzyme-linked
        immunospot assay. <em>J Virol</em> <strong>74</strong>:8541--9,
        2000. </li>
    <li><b>[Barber (1997)</b>] Barber97 L. D. Barber, L.
        Percival, K. L. Arnett, J. E. Gumperz, L. Chen, P.
        Parham. Polymorphism in the 1 Helix of the HLA-B Heavy
        Chain Can Have an Overriding Influence on Peptide-Binding
        Specificity. <em>J Immunol</em> <strong>158</strong>:1660--1669,
        1997. </li>
    <li><b>[Barber (1995)</b>] Barber95 L. D. Barber, B.
        Gillece-Castro, L. Percival, X. Li, C. Clayberger, P.
        Parham. Overlap in the repertoires of peptides bound in
        vivo by a group of related class I HLA-B allotypes. <em>Curr
        Biol</em> <strong>5</strong>:179--90, 1995. </li>
    <li><b>[Barouch (1995)</b>] Barouch95 D. Barouch, T. Friede,
        S. Stevanovic, L. Tussey, K. Smith, S. Rowland-Jones, V.
        Braud, A. McMichael, H. G. Rammensee. HLA-A2 subtypes are
        functionally distinct in peptide binding and
        presentation. <em>J Exp Med</em> <strong>182</strong>:1847--56,
        1995. </li>
    <li><b>[Bauer (1997)</b>] Bauer97 M. Bauer, M.
        Lucchiari-Hartz, R. Maier, G. Haas, B. Autran, K.
        Eichmann, R. Frank, B. Maier, A. Meyerhans. Structural
        constraints of HIV-1 Nef may curtail escape from
        HLA-B7-restricted CTL recognition. <em>Immunol Lett</em> <strong>55</strong>:119--22,
        1997. </li>
    <li><b>[Bertoletti (1998)</b>] Bertoletti98 A. Bertoletti, F.
        Cham, S. McAdam, T. Rostron, S. Rowland-Jones, S.
        Sabally, T. Corrah, K. Ariyoshi, H. Whittle. Cytotoxic T
        cells from human immunodeficiency virus type 2-infected
        patients frequently cross-react with different human
        immunodeficiency virus type 1 Clades. <em>J Virol </em><strong>72</strong>:2439--2448,
        1998. </li>
    <li><b>[Borrow (1997)</b>] Borrow97 P. Borrow, H. Lewicki, X.
        Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson,
        J. E. Gairin, B. H. Hahn, M. B. Oldstone, G. M. Shaw.
        Anti-viral pressure exerted by HIV-1-specific cytotoxic T
        lymphocytes (CTLs) during primary infection demonstrated
        by rapid selection of CTL escape virus. <em>Nat Med</em> <strong>3</strong>:205--11,
        1997. </li>
    <li><b>[Buseyne(1999)</b>] BuseynePerCom99 F. Buseyne.
        personal communication. unpublished 1999. </li>
    <li><b>[Buseyne (1996)</b>] Buseyne96 F. Buseyne, M. Fevrier,
        S. Garcia, M. L. Gougeon, Y. Riviere. Dual function of a
        human immunodeficiency virus (HIV)-specific cytotoxic
        T-lymphocyte clone: inhibition of HIV replication by
        noncytolytic mechanisms and lysis of HIV-infected CD4+
        cells. <em>Virology</em> <strong>225</strong>:248--53,
        1996. </li>
    <li><b>[Buseyne (1993)</b>] Buseyne93 F. Buseyne, M.
        McChesney, F. Porrot, S. Kovarik, B. Guy, Y. Riviere.
        Gag-specific cytotoxic T lymphocytes from human
        immunodeficiency virus type 1 infected individuals: gag
        epitopes are clustered in three regions of the p24 gag
        protein. <em>J Virol</em> <strong>67</strong>:694--702,
        1993. </li>
    <li><b>[Buseyne (1997)</b>] Buseyne97 F. Buseyne, S.
        Stevanovic, H. Rammensee, Y. Riviere. Characterization of
        an HIV-1 p24 gag epitope recognized by a CD8+ cytotoxic
        T-cell clone. <em>Immunol Lett </em><strong>55</strong>(3):145--149,
        1997. </li>
    <li><b>[Culmann(1999)</b>] CulmannPerCom99 B. Culmann.
        personal communication. unpublished 1999. </li>
    <li><b>[Culmann (1991)</b>] Culmann91 B. Culmann, E. Gomard,
        M.-P. Kieny, B. Guy, F. Dreyfus, A.-D. Saimot, D. Sereni,
        D. Sicard, J.-P. Levy. Six epitopes with human cytotoxic
        CD8+ cells in the central region of the HIV-1 Nef
        protein. <em>J Immunol</em> <strong>146</strong>:1560--1565,
        1991. </li>
    <li><b>[Culmann-Penciolelli (1994)</b>] CulmannPenciolelli94
        B. Culmann-Penciolelli, S. Lamhamedi-Cherradi, I.
        Couillin, N. Guegan, J. P. Levy, J. G. Guillet, E.
        Gomard. Identification of multirestricted immunodominant
        regions recognized by cytolytic T lymphocytes in the
        human immunodeficiency virus type 1 Nef protein (See
        comments in J Virol 1995 Jan;69(1):618). <em>J Virol</em>
        <strong>68</strong>:7336--43, 1994. </li>
    <li><b>[Dai (1992)</b>] Dai92 L. C. Dai, K. West, R. Littaua,
        K. Takahashi, F. A. Ennis. Mutation of human
        immunodeficiency virus type 1 at amino acid 585 on gp41
        results in loss of killing by CD8+ A24-restricted
        cytotoxic T lymphocytes. <em>J Virol</em> <strong>66</strong>:3151--3154,
        1992. </li>
    <li><b>[DiBrino (1994a)</b>] DiBrino94b M. DiBrino, K. C.
        Parker, D. H. Margulies, J. Shiloach, R. V. Turner, M.
        Garfield, W. E. Biddison WE, J. E. Coligan. The HLA-B14
        peptide binding site can accommodate peptides with
        different combinations of anchor residues. <em>J Biol
        Chem</em> <strong>269</strong>, 1994a. </li>
    <li><b>[DiBrino (1994b)</b>] DiBrino94a M. DiBrino, K. C.
        Parker, J. Shiloach, R. V. Turner, T. Tsuchida, M.
        Garfield, W. E. Biddison, J. E. Coligan. Endogenous
        peptides with distinct amino acid anchor residue motifs
        bind to HLA-A1 and HLA-B8. <em>J Immunol </em><strong>152</strong>:620--31,
        1994b. </li>
    <li><b>[DiBrino (1993)</b>] DiBrino93 M. DiBrino, K. C.
        Parker, J. S. et al. Endogenous peptides bound to HLA-A3
        possess a specific combination of anchor residues that
        permit identification of potential antigenic peptides. <em>Proc
        Natl Acad Sci USA</em> <strong>90</strong>:1508--1512,
        1993. </li>
    <li><b>[Dorrell (1999)</b>] Dorrell99 L. Dorrell, T. Dong, G.
        S. Ogg, S. Lister, S. McAdam, T. Rostron, C. Conlon, A.
        J. McMichael, S. L. Rowland-Jones. Distinct recognition
        of non-clade B human immunodeficiency virus type 1
        epitopes by cytotoxic T lymphocytes generated from donors
        infected in Africa. <em>J Virol </em><strong>73</strong>:1708--14,
        1999. </li>
    <li><b>[Dumrese (1998)</b>] Dumrese98 T. Dumrese, S.
        Stevanovic, F. H. Seeger, N. Yamada, Y. Ishikawa, K.
        Tokunaga, M. Takiguchi, H. Rammensee. HLA-A26 subtype A
        pockets accommodate acidic N-termini of ligands. <em>Immunogenetics</em>
        <strong>48</strong>:350--3, 1998. </li>
    <li><b>[Dupuis (1995)</b>] Dupuis95 M. Dupuis, S. K. Kundu,
        T. C. Merigan. Characterization of HLA-A*0201-restricted
        cytotoxic T-cell epitopes in conserved regions of the HIV
        type 1 gp160 protein. <em>J Immunol</em> <strong>155</strong>:2232--2239,
        1995. </li>
    <li><b>[Englehard (1993)</b>] Englehard93 V. H. Englehard, E.
        L. Huczko, W. Bodner et al. Peptides bound to HLA-B7
        determined by mass spectrometry. <em>J Cell Biochem Suppl
        </em>1993 <strong>17C</strong>:56, 1993. </li>
    <li><b>[Falk (1995a)</b>] Falk95a K. Falk, O. Rotzschke, M.
        Takiguchi, V. Gnau, S. Stevanovic, G. Jung, H. Rammensee.
        Peptide motifs of HLA-B38 and B39 molecules. <em>Immunogenetics</em>
        <strong>41</strong>:162--164, 1995a. </li>
    <li><b>[Falk (1995b)</b>] Falk95b K. Falk, O. Rotzschke, M.
        Takiguchi, V. Gnau, S. Stevanovic, G. Jung, H. Rammensee.
        Peptide motifs of HLA-B58, B60, B61, and B62 molecules. <em>Immunogenetics</em>
        <strong>41</strong>:165--168, 1995b. </li>
    <li><b>[Falk (1994)</b>] Falk94 K. Falk, O. Rotzschke, B.
        Grahavac. Allele-specific peptide motifs of HLA-C
        molecules. <em>Proc Natl Acad Sci USA </em><strong>90</strong>:12005--12009,
        1994. </li>
    <li><b>[Falk (1993)</b>] Falk93 K. Falk, O. Rotzschke, B.
        Grahovac, D. Schendel, S. Stevanovic, G. Jung, H. G.
        Rammensee. Peptide motifs of HLA-B35 and -B37 molecules
        [published erratum appears in Immunogenetics
        1994;39(5):379] . <em>Immunogenetics</em> <strong>38</strong>:161--2,
        1993. </li>
    <li><b>[Falk (1991)</b>] Falk91 K. Falk, O. Rotzschke, S.
        Stevanovic, G. Jung, H.-G. Rammensee. Allele-specific
        motifs revealed by sequencing of self-peptides eluted
        from MHC molecules. <em>Nature</em> <strong>351</strong>:290--296,
        1991. </li>
    <li><b>[Fukada (1999)</b>] Fukada99 K. Fukada, Y. Chujoh, H.
        Tomiyama, K. Miwa, Y. Kaneko, S. Oka, M. Takiguchi.
        HLA-A*1101-restricted cytotoxic T lymphocyte recognition
        of HIV-1 Pol protein [letter] . <em>AIDS</em> <strong>13</strong>:1413--4,
        1999. </li>
    <li><b>[Gotch (1993)</b>] Gotch93 F. Gotch, S. N. McAdam, C.
        E. Allsopp et al. Cytotoxic T-cells in HIV-2 seropositive
        Gambians. Identification of a virus specific
        MHC-restricted peptide epitope. <em>J Immunol</em> <strong>151</strong>:3361--3369,
        1993. </li>
    <li><b>[Goulder (1996a)</b>] Goulder96b P. Goulder, C.
        Conlon, K. McIntyre, A. McMichael. Identification of a
        novel human leukogen antigen A26-restricted epitope in a
        conserved region of Gag. <em>AIDS</em> <strong>10(12)</strong>:1441--1443,
        1996a. </li>
    <li><b>[Goulder (1997a)</b>] Goulder97 P. Goulder, A. Sewell,
        D. Lalloo, D. Price, J. Whelan, J. Evans, G. Taylor, G.
        Luzzi, P. Giangrande, R. Phillips, A. J. McMichael.
        Patterns of immunodominance in HIV-1-specific cytotoxic T
        lymphocyte responses in two human histocompatibility
        leukocyte antigens (HLA)-identical siblings with
        HLA-A*0201 are influenced by epitope mutation. <em>J Exp
        Med</em> <strong>8</strong>:1423--33, 1997a. </li>
    <li><b>[Goulder(2000)</b>] GoulderPerCom00 P. J. Goulder.
        personal communication. unpublished 2000. </li>
    <li><b>[Goulder (2001a)</b>] Goulder01a P. J. Goulder, M. M.
        Addo, M. A. Altfeld, E. S. Rosenberg, Y. Tang, U.
        Govender, N. Mngqundaniso, K. Annamalai, T. U. Vogel, M.
        Hammond, M. Bunce, H. M. Coovadia, B. D. Walker. Rapid
        Definition of Five Novel HLA-A*3002-Restricted Human
        Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte
        Epitopes by Elispot and Intracellular Cytokine Staining
        Assays. <em>J Virol</em> <strong>75</strong>:1339--1347,
        2001a. </li>
    <li><b>[Goulder (2001b)</b>] Goulder01b P. J. Goulder, M. A.
        Altfeld, E. S. Rosenberg, T. Nguyen, Y. Tang, R. L.
        Eldridge, M. M. Addo, S. He, J. S. Mukherjee, M. N.
        Phillips, M. Bunce, S. A. Kalams, R. P. Sekaly, B. D.
        Walker, C. Brander. Substantial Differences in
        Specificity of HIV-specific Cytotoxic T Cells in Acute
        and Chronic HIV Infection. <em>J Exp Med </em><strong>193</strong>:181--194,
        2001b. </li>
    <li><b>[Goulder (1997b)</b>] Goulder97f P. J. Goulder, M.
        Bunce, G. Luzzi, R. E. Phillips, A. J. McMichael.
        Potential underestimation of HLA-C-restricted cytotoxic
        T-lymphocyte responses. <em>AIDS</em> <strong>11(15)</strong>:1884--1886,
        1997b. </li>
    <li><b>[Goulder(1999)</b>] GoulderPerCom99 P. J. R. Goulder.
        personal communication. unpublished 1999. </li>
    <li><b>[Goulder (2000c)</b>] Goulder00c P. J. R. Goulder, C.
        Brander, K. Annamalai, N. Mngqundaniso, U. Govender, Y.
        Tang, S. He, K. E. Hartman, C. A. O'Callaghan, G. S. Ogg,
        M. A. Altfeld, E. S. Rosenberg, H. Cao, S. A. Kalams, M.
        Hammond, M. Bunce, S. I. Pelton, S. A. Burchett, K.
        McIntosh, H. M. Coovadia, B. D. Walker. Differential
        narrow focusing of immunodominant HIV Gag-specific CTL
        responses in infected African and Caucasoid adults and
        children. <em>J. Virology</em> <strong>74</strong>:5679--90,
        2000. </li>
    <li><b>[Goulder (1996b)</b>] Goulder96 P. J. R. Goulder, M.
        Bunce, P. Krausa, K. McIntyre, S. Crowley, B. Morgan, A.
        Edwards, P. Giangrande, R. E. Phillips, A. J. McMichael.
        Novel, cross-restricted, conserved and immunodominant
        cytotoxic T lymphocyte epitopes in slow HIV Type 1
        infection. <em>AIDS Res and Hum Retroviruses</em> <strong>12</strong>:1691--1698,
        1996b. </li>
    <li><b>[Goulder (1997c)</b>] Goulder97b P. J. R. Goulder, R.
        E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A.
        Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A.
        McMichael, S. Rowland-Jones. Late Escape from an
        immunodominant cytotoxic T-lymphocyte response associated
        with progression to AIDS. <em>Nature Med </em><strong>3</strong>:212--216,
        1997c. </li>
    <li><b>[Goulder (1997d)</b>] Goulder97c P. J. R. Goulder, S.
        W. Reid, D. A. Price, C. A. O'Callaghan, A. J. McMichael,
        R. E. Phillips, E. Y. Jones. Combined structural and
        immunological refinement of HIV-1 HLA-B8 restricted
        cytotoxic T lymphocyte epitopes. <em>Eur J Immunol</em> <strong>27</strong>:1515--1521,
        1997d. </li>
    <li><b>[Goulder (2000b)</b>] Goulder00b P. J. R. Goulder, Y.
        Tang, S. I. Pelton, B. D. Walker. HLA-B57-restricted CTL
        activity in a single infected subject towards two optimal
        HIV epitopes, one of which is entirely contained within
        the other. <em>J Virol</em> <strong>74</strong>:5291--9,
        2000. </li>
    <li><b>[Haas(1999)</b>] HaasPerCom99 G. Haas. personal
        communication. unpublished 1999. </li>
    <li><b>[Haas (1996)</b>] Haas96 G. Haas, U. Plikat, P. Debre,
        M. Lucchiari, C. Katlama, Y. Dudoit, O. Bonduelle, M.
        Bauer, H. Ihlenfeldt, G. Jung, B. Maier, A. Meyerhans, B.
        Autran. Dynamics of viral variants in HIV-1 Nef and
        specific cytotoxic T lymphocytes in vivo. <em>J Immunol</em>
        <strong>157</strong>:4212--4221, 1996. </li>
    <li><b>[Haas (1998)</b>] Haas98 G. Haas, A. Samri, E. Gomard,
        A. Hosmalin, J. Duntze, J. M. Bouley, H. G. Ihlenfeldt,
        C. Katlama, B. Autran. Cytotoxic T-cell responses to
        HIV-1 reverse transcriptase, integrase and protease. <em>AIDS</em>
        <strong>12(12)</strong>:1427--36, 1998. </li>
    <li><b>[Harrer (1996a)</b>] Harrer96a E. Harrer, T. Harrer,
        P. Barbosa, M. Feinberg, R. P. Johnson, S. Buchbinder, B.
        D. Walker. Recognition of the highly conserved YMDD
        region in the human immunodeficiency virus type 1 reverse
        transcriptase by HLA-A2-restricted cytotoxic T
        lymphocytes from an asymptomatic long-term nonprogresser.
        <em>J Inf Dis</em> <strong>173</strong>:476--479, 1996a. </li>
    <li><b>[Harrer (1998)</b>] Harrer98 T. Harrer, E. Harrer, P.
        Barbosa, F. Kaufmann, R. Wagner, S. Bruggemann, J. R.
        Kalden, M. Feinberg, R. P. Johnson, S. Buchbinder, B. D.
        Walker. Recognition of two overlapping CTL epitopes in
        HIV-1 p17 by CTL from a long-term nonprogressing
        HIV-1-infected individual. <em>J Immunol </em><strong>161</strong>:4875--81,
        1998. </li>
    <li><b>[Harrer (1996b)</b>] Harrer96b T. Harrer, E. Harrer,
        S. A. Kalams, P. Barbosa, A. Trocha, R. P. Johnson, T.
        Elbeik, M. B. Feinberg, S. P. Buchbinder, B. D. Walker.
        Cytotoxic T lymphocytes in asymptomatic long-term
        nonprogressing HIV-1 infection. Breadth and specificity
        of the response and relation to in vivo viral
        quasispecies in a person with prolonged infection and low
        viral load.<em> J Immunol</em> <strong>156</strong>:2616--2623,
        1996b. </li>
    <li><b>[Hay(1999)</b>] HayPerCom99 Hay. personal
        communication. unpublished 1999. </li>
    <li><b>[Hill (1992)</b>] Hill92b A. V. Hill, J. Elvin, A. C.
        Willis, M. Aidoo, C. E. Allsopp, F. M. Gotch, X. M. Gao,
        M. Takiguchi, B. M. Greenwood, A. R. Townsend et al.
        Molecular analysis of the association of HLA-B53 and
        resistance to severe malaria (see comments). <em>Nature</em>
        <strong>360</strong>:434--9, 1992. </li>
    <li><b>[Ikeda-Moore (1998)</b>] IkedaMoore98 Y. Ikeda-Moore,
        H. Tomiyama, M. Ibe, S. Oka, K. Miwa, Y. Kaneko, M.
        Takiguchi. Identification of a novel HLA-A24-restricted
        cytotoxic T-lymphocyte epitope derived from HIV-1 Gag
        protein. <em>AIDS</em> <strong>12</strong>:2073--4, 1998.
    </li>
    <li><b>[Jin (2000)</b>] Jin00 X. Jin, C. G. Roberts, D. F.
        Nixon, J. T. Safrit, L. Q. Zhang, Y. X. Huang, N.
        Bhardwaj, B. Jesdale, A. S. DeGroot, R. A. Koup.
        Identification of subdominant cytotoxic T lymphocyte
        epitopes encoded by autologous HIV type 1 sequences,
        using dendritic cell stimulation and computer-driven
        algorithm. <em>AIDS Res Hum Retroviruses</em> <strong>16</strong>:67--76,
        2000. </li>
    <li><b>[Johnson(1999)</b>] JohnsonPerCom99 R. P. Johnson.
        personal communication. unpublished 1999. </li>
    <li><b>[Johnson (1994)</b>] Johnson94 R. P. Johnson, S. A.
        Hammond, A. Trocha, R. F. Siliciano, B. D. Walker.
        Induction of a major histocompatibility complex class
        I-restricted cytotoxic T-lymphocyte response to a highly
        conserved region of human immunodeficiency virus type 1
        (HIV-1) gp120 in seronegative humans immunized with a
        candidate HIV-1 vaccine. <em>J Virol</em> <strong>68</strong>:3145--3153,
        1994. </li>
    <li><b>[Johnson (1992)</b>] Johnson92 R. P. Johnson, A.
        Trocha, T. M. Buchanan, B. D. Walker. Identification of
        overlapping HLA class I-restricted cytotoxic T-cell
        epitopes in a conserved region of the human
        immunodeficiency virus type 1 envelope glycoprotein:
        definition of minimum epitopes and analysis of the
        effects of sequence variation. <em>J Exp Med </em><strong>175</strong>:961--971,
        1992. </li>
    <li><b>[Johnson (1993)</b>] Johnson93 R. P. Johnson, A.
        Trocha, T. M. Buchanan, B. D. Walker. Recognition of a
        highly conserved region of human immunodeficiency virus
        type 1 gp120 by an HLA-Cw4-restricted cytotoxic
        T-lymphocyte clone. <em>J Virol</em> <strong>67</strong>:438--445,
        1993. </li>
    <li><b>[Johnson (1991)</b>] Johnson91 R. P. Johnson, A.
        Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M.
        Buchanan, B. D. Walker. HIV-1 gag-specific cytotoxic T
        lymphocytes recognize multiple highly conserved epitopes.
        Fine specificity of the gag-specific response defined by
        using unstimulated peripheral blood mononuclear cells and
        cloned effector cells. <em>J Immunol</em> <strong>147</strong>:1512--1521,
        1991. </li>
    <li><b>[Johnson Walker(1994)</b>] Johnson94b R. P. Johnson B.
        D. Walker. CTL in HIV-1 infection: Responses to
        structural proteins. <em>Curr Topics Microbiol Immunol</em>
        <strong>189</strong>:35--63, 1994. </li>
    <li><b>[Kaul Rowland-Jones(1999)</b>] Kaul99 R. Kaul S. L.
        Rowland-Jones. Methods of Detection of HIV-specific CTL
        and Their Role in Protection Against HIV Infection. In B.
        Korber and C. Brander and B. Haynes and J. Moore and R.
        Koup and B. Walker and D. Watkins, editor, HIV Molecular
        Immunology Database: 1999, chapter IV, pages 35--44. Los
        Alamos National Laboratory, 1999. </li>
    <li><b>[Klenerman (1996)</b>] Klenerman96 P. Klenerman, G.
        Luzzi, K. McIntyre, R. Phillips, A. McMichael.
        Identification of a novel HLA-A25 restricted epitope in a
        conserved region of p24 gag (positions 71-80). <em>AIDS</em>
        <strong>10</strong>:348--350, 1996. </li>
    <li><b>[Koenig (1990)</b>] Koenig90 S. Koenig, T. R. Fuerst,
        L. V. Wood, R. M. Woods, J. A. Suzich, G. M. Jones, V. F.
        de la Cruz, R. T. Davey, S. Venkatesan, B. Moss, W. E.
        Biddison, A. S. Fauci. Mapping the fine specificity of a
        cytotoxic T-cell response to HIV-1 Nef protein. <em>J
        Immunol </em><strong>145</strong>:127--135, 1990. </li>
    <li><b>[Kurane West(1999)</b>] KuraneWestPerCom99 I. Kurane
        K. West. personal communication. unpublished 1999. </li>
    <li><b>[Lewinsohn (1999)</b>] LewinsohnRiddellPerCom99
        Lewinsohn, , S. Riddell. personal communication.
        unpublished 1999. </li>
    <li><b>[Lewinsohn(1999)</b>] LewinsohnPerCom99 D. Lewinsohn.
        personal communication. unpublished 1999. </li>
    <li><b>[Lieberman(1999)</b>] LiebermanPerCom99 J. Lieberman.
        personal communication. unpublished 1999. </li>
    <li><b>[Lieberman (1992)</b>] Lieberman92 J. Lieberman, J. A.
        Fabry, M.-C. Kuo, P. Earl, B. Moss, P. R. Skolnik.
        Cytotoxic T lymphocytes from HIV-1 seropositive
        individuals recognize immunodominant epitopes in gp160
        and reverse transcriptase. <em>J Immunol</em> <strong>148</strong>:2738--2747,
        1992. </li>
    <li><b>[Maier Autran(1999)</b>] MaierAutranPerCom99 B. Maier
        B. Autran. personal communication. unpublished 1999. </li>
    <li><b>[Maier (1994)</b>] Maier94 R. Maier, K. Falk, O.
        Rotzschke, B. Maier, V. Gnau, S. Stevanovic, G. Jung, H.
        G. Rammensee, A. Meyerhans. Peptide motifs of HLA-A3,
        -A24, and -B7 molecules as determined by pool sequencing.
        <em>Immunogenetics</em> <strong>40</strong>:306--8, 1994.
    </li>
    <li><b>[McKinney (1999)</b>] McKinney99 D. McKinney, D.
        Lewinson, S. Riddell, P. Greenberg, D. Mosier. The
        Antiviral Activity of HIV-Specific CD8+ CTL clones is
        limited by elimination due to encounter with HIV-infected
        targets. <em>J. Immuno </em><strong>163</strong>:861--7,
        1999. </li>
    <li><b>[Nixon (1988)</b>] Nixon88 D. Nixon, A. Townsend, J.
        Elvin, C. Rizza, J. Gallway, A. McMichael. HIV-1
        gag-specific cytotoxic T lymphocytes defined with
        recombinant vaccinia virus and synthetic peptides. <em>Nature</em>
        <strong>336</strong>:484--487, 1988. </li>
    <li><b>[Nixon (1999)</b>] Nixon99 D. F. Nixon, D. Douek, P.
        J. Kuebler, X. Jin, M. Vesanen, S. Bonhoeffer, Y. Cao, R.
        A. Koup, D. D. Ho, M. Markowitz. Molecular tracking of an
        Human Immunodeficiency Virus nef specific cytotoxic
        T-cell clone shows persistence of clone-specific T-cell
        receptor DNA but not mRNA following early combination
        antiretroviral therapy. <em>Immunol Lett </em><strong>66</strong>:219--28,
        1999. </li>
    <li><b>[Ogg (1998)</b>] Ogg98 G. S. Ogg, X. Jin, S.
        Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P.
        Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, A.
        Hurley, M. Markowitz, D. D. Ho, D. F. Nixon, A. J.
        McMichael. Quantitation of HIV-1-specific cytotoxic T
        lymphocytes and plasma load of viral RNA. <em>Science</em>
        <strong>279</strong>:2103--6, 1998. </li>
    <li><b>[Parker (1994)</b>] Parker94 K. C. Parker, M. A.
        Bednarek, J. E. Coligan. Scheme for ranking potential
        HLA-A2 binding peptides based on independent binding of
        individual peptide side-chains. <em>J Immunol</em> <strong>152</strong>,
        1994. </li>
    <li><b>[Parker (1992)</b>] Parker92 K. C. Parker, M. A.
        Bednarek, L. K. Hull, U. Utz, B. C. H. J. Zweerink, W. E.
        Biddison, J. E. Coligan. Sequence motifs important for
        peptide binding to the human MHC class I molecule,
        HLA-A2. <em>J Immunol</em> <strong>149</strong>, 1992. </li>
    <li><b>[Price (1997)</b>] Price97 D. A. Price, P. J. Goulder,
        P. Klenerman, A. K. Sewell, P. J. Easterbrook, M. Troop,
        C. R. Bangham, R. E. Phillips. Positive selection of
        HIV-1 cytotoxic T lymphocyte escape variants during
        primary infection. <em>Proc Natl Acad Sci USA</em> <strong>94</strong>:1890--5,
        1997. </li>
    <li><b>[Rammensee (1999)</b>] Rammensee99 H. Rammensee, J.
        Bachmann, N. Emmerich, S. Stevanovic. SYFPEITHI: An
        Internet Database for MHC Ligands and Peptide Motifs
        1999. </li>
    <li><b>[Rammensee (1995)</b>] Rammensee95 H.-G. Rammensee, T.
        Friede, S. Stevanovic. MHC ligands and peptide motifs:
        first listing. <em>Immunogenetics</em> <strong>41</strong>:178--228,
        1995. </li>
    <li><b>[Rowland-Jones(1999)</b>] Rowland-JonesPerCom99 S.
        Rowland-Jones. personal communication. unpublished 1999. </li>
    <li><b>[Rowland-Jones (1998)</b>] Rowland-Jones98 S. L.
        Rowland-Jones, T. Dong, K. R. Fowke, J. Kimani, P.
        Krausa, H. Newell, T. Blanchard, K. Ariyoshi, J. Oyugi,
        E. Ngugi, J. Bwayo, K. S. MacDonald, A. J. McMichael, F.
        A. Plummer. Cytotoxic T cell responses to multiple
        conserved HIV epitopes in HIV- resistant prostitutes in
        Nairobi [see comments] . <em>J Clin Invest</em> <strong>102</strong>:1758--65,
        1998. </li>
    <li><b>[Rowland-Jones (1993)</b>] RowlandJones93a S. L.
        Rowland-Jones, S. H. Powis, J. Sutton, I. Mockridge, F.
        M. Gotch, N. Murray, A. B. Hill, W. M. Rosenberg, J.
        Trowsdale, A. J. McMichael. An antigen processing
        polymorphism revealed by HLA-B8-restricted cytotoxic T
        lymphocytes which does not correlate with TAP gene
        polymorphism.<em> Eur J Immunol</em> <strong>23</strong>:1999--2004,
        1993. </li>
    <li><b>[Rowland-Jones (1995)</b>] RowlandJones95 S. L.
        Rowland-Jones, J. Sutton, K. Ariyoshi, T. Dong and , F.
        Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T.
        Corrah, M. Takiguchi, T. Schultz, A. McMichael, H.
        Whittle. HIV-specific cytotoxic T-cells in HIV-exposed
        but uninfected Gambian women.<em> Nature Medicine</em> <strong>1:59</strong>--64,
        1995. </li>
    <li><b>[Safrit (1994a)</b>] Safrit94a J. T. Safrit, C. A.
        Andrews, T. Zhu, D. D. Ho, R. A. Koup. Characterization
        of human immunodeficiency virus type 1-specific cytotoxic
        T lymphocyte clones isolated during acute seroconversion:
        recognition of autologous virus sequences within a
        conserved immunodominant epitope. <em>J Exp Med </em><strong>179</strong>:463--472,
        1994a. </li>
    <li><b>[Safrit (1994b)</b>] Safrit94b J. T. Safrit, A. Y.
        Lee, C. A. Andrews, R. A. Koup. A region of the Third
        Variable Loop of HIV-1 gp120 is recognized by
        HLA-B7-Restricted CTLs from two acute seroconversion
        patients. <em>J Immunol</em> <strong>153</strong>:3822--3830,
        1994b. </li>
    <li><b>[Seeger (1998)</b>] Seeger98 F. H. Seeger, D. Arnold,
        T. Dumrese, H. de la Salle, D. Fricker, H. Schild, H. G.
        Rammensee, S. Stevanovic. The HLA-B* 1516 motif
        demonstrates HLA-B-specific P2 pocket characteristics. <em>Immunogenetics</em>
        <strong>48</strong>:156--60, 1998. </li>
    <li><b>[Shankar (1996)</b>] Shankar96 P. Shankar, J. A.
        Fabry, D. M. Fong, J. Lieberman. Three regions of HIV-1
        gp160 contain clusters of immunodominant CTL epitopes. <em>Immunol
        Lett</em> <strong>52</strong>:23--30, 1996. </li>
    <li><b>[Shiga (1996)</b>] Shiga96 H. Shiga, T. Shioda, H.
        Tomiyama, Y. Takamiya, S. Oka, S. Kimura, Y. Yamaguchi,
        T. Gojoubori, H. G. Rammensee, K. Miwa, M. Takiguchi.
        Identification of multiple HIV-1 cytotoxic T-cell
        epitopes presented by human leukocyte antigen B35
        molecule. <em>AIDS</em> <strong>10</strong>:1075--1083,
        1996. </li>
    <li><b>[Sipsas (1997)</b>] Sipsas97 N. V. Sipsas, S. A.
        Kalams, A. Trocha, S. He, W. A. Blattner, B. D. Walker,
        R. P. Johnson. Identification of type-specific cytotoxic
        T lymphocyte responses to homologous viral proteins in
        laboratory workers accidentally infected with HIV-1. <em>J
        Clin Invest</em> <strong>99</strong>:752--62, 1997. </li>
    <li><b>[Sutton (1993)</b>] Sutton93 J. Sutton, S.
        Rowland-Jones, W. Rosenberg, D. Nixon, F. Gotch, X.-M.
        Gao, N. Murray, A. Spoonas, P. Driscoll, M. Smith, A.
        Willis, A. McMichael. A sequence pattern for peptides
        presented to cytotoxic T lymphocytes by HLA B8 revealed
        by analysis of epitopes and eluted peptides. <em>Eur J
        Immunol </em><strong>23</strong>:447--453, 1993. </li>
    <li><b>[Takahashi (1991)</b>] Takahashi91 K. Takahashi, L.-C.
        Dai, T. R. Fuerst, W. E. Biddison, P. L. Earl, B. Moss,
        F. A. Ennis. Specific lysis of human immunodeficiency
        virus type 1-infected cells by a HLA-A3.1-restricted CD8+
        cytotoxic T-lymphocyte clone that recognizes a conserved
        peptide sequence within the gp41 subunit of the envelope
        protein. <em>Proc Natl Acad Sci USA</em> <strong>88</strong>:10277--10281,
        1991. </li>
    <li><b>[Threlkeld (1997)</b>] Threlkeld97 S. C. Threlkeld, P.
        A. Wentworth, S. A. Kalams, B. M. Wilkes, D. J. Ruhl, E.
        Kepgh, J. Sidney, S. Southwood, B. D. Walker, A. Sette.
        Degenerate and promiscuous recognition by CTL of peptides
        presented by the MHC class I A3-like superfamily. <em>J
        Immunol </em><strong>159 (4)</strong>:1648--1657, 1997. </li>
    <li><b>[Tomiyama (1999)</b>] Tomiyama99 H. Tomiyama, T.
        Sakaguchi, K. Miwa, S. Oka, A. Iwamoto, Y. Kaneko, M.
        Takiguchi. Identification of multiple HIV-1 CTL epitopes
        presented by HLA-B*5101 molecules. <em>Hum Immunol</em> <strong>60</strong>:177--86,
        1999. </li>
    <li><b>[Tsomides (1991)</b>] Tsomides91 T. J. Tsomides, B. D.
        Walker, H. N. Eisen. An optimal viral peptide recognized
        by CD8+ T-cells binds very tightly to the restricting
        class I major histocompatibility complex protein on
        intact cells but not to the purified class I protein. <em>Proc
        Natl Acad Sci USA</em> <strong>88</strong>:11276--11280,
        1991. </li>
    <li><b>[van Baalen Gruters(2000)</b>] vanBaalenPerCom00 C.
        van Baalen R. Gruters. personal communication.
        unpublished 2000. </li>
    <li><b>[van Baalen (1996)</b>] vanBaalen96 C. A. van Baalen,
        M. R. Klein, R. C. Huisman, M. E. Dings, S. R. Kerkhof
        Garde, A. M. Geretti, R. Gruters, C. A. van Els, F.
        Miedema, A. D. Osterhaus. Fine-specificity of cytotoxic T
        lymphocytes which recognize conserved epitopes of the Gag
        protein of human immunodeficiency virus type 1. <em>J Gen
        Virol</em> <strong>77</strong>:1659--1665, 1996. </li>
    <li><b>[van der Burg (1997)</b>] vanderBurg97 S. H. van der
        Burg, M. R. Klein, O. Pontesilli, A. M. Holwerda, J.
        Drijfhout, W. M. Kast, F. Miedema, C. J. M. Melief. HIV-1
        reverse transcriptase-specific CTL against conserved
        epitopes do not protect against progression to AIDS. <em>J
        Immunol</em> <strong>159</strong>:3648--3654, 1997. </li>
    <li><b>[Walker (1989)</b>] Walker89 B. D. Walker, C. Flexner,
        K. Birch-Limberger, L. Fisher, T. J. Paradis, A.
        Aldovini, R. Young, B. Moss, R. T. Schooley. Long-term
        culture and fine specificity of human cytotoxic
        T-lymphocyte clones reactive with human immunodeficiency
        virus type 1. <em>Proc Natl Acad Sci USA</em> <strong>86</strong>:9514--9518,
        1989. </li>
    <li><b>[Wilkes(1999)</b>] WilkesPerCom99 B. Wilkes. personal
        communication. unpublished 1999. </li>
    <li><b>[Wilkes Ruhl(1999)</b>] WilkesRuhlPerCom99 B. M.
        Wilkes D. J. Ruhl. personal communication. unpublished
        1999. </li>
    <li><b>[Wilkes Ruhl Goulder (1999)</b>]
        WilkesRuhlGoulderPerCom99 B. M. Wilkes, D. J. Ruhl and,
        P. Goulder. personal communication. unpublished 1999. </li>
    <li><b>[Wilson(1999b)</b>] WilsonPerCom99 C. Wilson. personal
        communication. unpublished 1999. </li>
    <li><b>[Wilson (1999a)</b>] Wilson99a C. C. Wilson, R. C.
        Brown, B. T. Korber, B. M. Wilkes, D. J. Ruhl, D.
        Sakamoto, K. Kunstman, K. Luzuriaga, I. C. Hanson, S. M.
        Widmayer, A. Wiznia, S. Clapp, A. J. Ammann, R. A. Koup,
        S. M. Wolinsky, B. D. Walker. Frequent detection of
        escape from cytotoxic T-lymphocyte recognition in
        perinatal human immunodeficiency virus (HIV) type 1
        transmission: the ariel project for the prevention of
        transmission of HIV from mother to infant. <em>J Virol</em>
        <strong>73</strong>:3975--85, 1999. </li>
    <li><b>[Wilson (1997)</b>] Wilson97 C. C. Wilson, S. A.
        Kalams, B. M. Wilkes, D. J. Ruhl, F. Gao, B. H. Hahn, I.
        C. Hanson, K. Luzuriaga, S. Wolinsky, R. Koup, S. P.
        Buchbinder, R. P. Johnson, B. D. Walker. Overlapping
        epitopes in human immunodeficiency virus type 1 gp120
        presented by HLA A, B, and C molecules: effects of viral
        variation on cytotoxic T-lymphocyte recognition. <em>J
        Virol</em> <strong>71</strong>:1256--64, 1997. </li>
    <li><b>[Yu Altfeld(2001)</b>] YuPerCom01 X. Yu M. Altfeld.
        personal communication. unpublished 2001. </li>
    <li><b>[Zhang (1993)</b>] Zhang93 Q.-I. Zhang, R. Gavioli, G.
        Klein, M. G. Masucci. An HLA-All-specific motif in
        nonamer peptides derived from viral and cellular
        proteins. <em>Proc Natl Acad Sci USA</em> <strong>90</strong>:2217--2221,
        1993. </li>
</ol>
</body>
</html>
</td></tr>
	    <tr><td><table bgcolor="white" width="100%" align="center" cellpadding="0" cellspacing="0" border="0">
  <tr><td>&nbsp;</td></tr>
  <tr><td colspan=2 align=center>Questions or comments? Contact us at <a href="mailto:seq-info@t10.lanl.gov"><font color="#8f8fbd" face="helvetica">seq-info@t10.lanl.gov</font></a></td></tr>
  <tr><td>&nbsp;</td></tr>
</table>



</td></tr>
	  </table>  
        </td>
      </tr>	
    </table>
  </body>
</html>      

<!-- no autohandlers upstream -->


